Statement of Organization, Functions, and Delegations of Authority, 38600-38601 [07-3427]
Download as PDF
<![CDATA[
38600
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Respondents
Laboratory Test Result Form .................................................................................................
Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13605 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP),
National Center for Environmental
Health (NCEH)
pwalker on PROD1PC71 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5 p.m., September 18, 2007.
8:30 a.m.–12:30 p.m., September 19, 2007.
Place: Radisson Plaza Hotel Minneapolis,
35 South 7th Street, Minneapolis, MN 55402,
Telephone: (612) 339–4900.
Open to the public, limited only by the
space available. The meeting room
accommodates approximately 75 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The Committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommends improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: The meeting will
include discussion on the potential
approaches to strengthen existing strategies
to achieve the Healthy People 2010 goal of
eliminating Elevated Blood Lead Levels as a
Public Health Problem in the United States
by 2010, the development of a prevention
based research agenda, and the study designs
related to adverse effects from Blood Lead
Levels (BLLs) < 10 µg/dl; and updates on the
school performance and concurrent BLLs.
Agenda items are subject to change as
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
VerDate Aug<31>2005
19:05 Jul 12, 2007
Jkt 211001
Contact Person for More Information:
Claudine Johnson, Clerk, Lead Poisoning
Prevention Branch, Division of
Environmental Emergency Health Services,
NCEH, CDC, 4770 Buford Hwy, NE., Mailstop
F–40, Atlanta, GA 30341, Telephone (770)
488–3629, Fax (770) 488–3635.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13596 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
Number of
responses per
respondent
754
Average burden
per response
(in hours)
2
10/60
evaluation of research grant applications in
response to RFA DP07–707, ‘‘Racial and
Ethnic Approaches to Community Health
Across the United States (REACH US).’’
For Further Information Contact: Thijuanie
Lockhart, Program & Management Analyst,
CDC, 4770 Buford Highway, NE., Mail Stop
K–30, Atlanta, GA 30341, Telephone (404)
488–5303.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13602 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Racial and Ethnic
Approaches to Community Health
Across the United States (REACH US),
Request for Applications (RFA) DP07–
707
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Times and Dates: 3 p.m.–8 p.m., July 31,
2007 (Closed), 8 a.m.–5 p.m., August 1, 2007
(Closed), 8 a.m.–5 p.m., August 2, 2007
(Closed), 3 p.m.–8 p.m., August 6, 2007
(Closed), 8 a.m.–5 p.m., August 7, 2007
(Closed), 8 a.m.–5 p.m., August 8, 2007
(Closed), 8 a.m.–5 p.m., August 9, 2007
(Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Sullivan Road, Atlanta, GA
30337, Telephone (800) 454–6835.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–67776, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 35491–35492,
dated June 28, 2007) is amended to
reflect the establishment of the
Extramural Research Program Office
within the National Center for Chronic
Disease Prevention and Health
Promotion, Coordinating Center for
Health Promotion, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the functional statement
for the Program Services Branch
(CUC13), Office of the Director (CUC1),
National Center for Chronic Disease
Prevention and Health Promotion
(CUC), insert the following:
Extramural Research Program Office
(CUC18). The Extramural Research
Program Office (ERPO) plans, develops,
E:\FR\FM\13JYN1.SGM
13JYN1
Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
coordinates, and evaluates extramural
research activities in cooperation with
centers, divisions, and offices within the
Coordinating Center for Health
Promotion. In carrying out its mission,
the ERPO: (1) Coordinates, monitors,
and directs the extramural research
program which is designed to address
center priorities; (2) provides scientific
leadership in the processes supporting
extramural research of the center; (3)
works with National Centers to prepare
and promote initiatives to stimulate
extramural research in relevant priority
areas; (4) coordinates and conducts indepth external peer review and
secondary program relevance review of
extramural research applications by use
of consultant expert panels; (5) makes
recommendations to the center directors
on award selections on the basis of
secondary reviews; (6) staff members
serve as the program officials and work
with CDC grants management officers,
and the Procurement and Grants Office
to implement and monitor the scientific,
technical, and administrative aspects of
awards; (7) facilitates scientific
collaborations between external and
internal investigators; (8) evaluates
extramural research progress and impact
and disseminates findings; and (9)
assists Office of the Chief Science
Officer, CDC, in developing extramural
research policies and oversees the
implementation of those policies within
the center.
Dated: June 28, 2007.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 07–3427 Filed 7–12–07; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10137, CMS–
10237 and 10214, CMS–10242, CMS–379
and CMS–10102]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
pwalker on PROD1PC71 with NOTICES
AGENCY:
VerDate Aug<31>2005
19:05 Jul 12, 2007
Jkt 211001
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Application for
Prescription Drug Plans (PDP);
Application for Medicare Advantage
Prescription Drug (MA–PD);
Application for Cost Plans to Offer
Qualified Prescription Drug Coverage;
Application for Employer Group Waiver
Plans to Offer Prescription Drug
Coverage; Service Area Expansion
Application for Prescription Drug
Coverage; Use: Collection of this
information is mandated in Part D of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003. The application requirements are
codified in Subpart K of 42 CFR 423.
Coverage for the prescription drug
benefit is provided through prescription
drug plans (PDPs) that offer drug-only
coverage, or through Medicare
Advantage (MA) organizations that offer
integrated prescription drug and health
care coverage (MA–PD plans). PDPs
must offer a basic drug benefit.
Medicare Advantage Coordinated Care
Plans (MA–CCPs) must offer either a
basic benefit or may offer broader
coverage for no additional cost.
Medicare Advantage Private Fee for
Service Plans (MA–PFFS) may choose to
offer a Part D benefit. Cost Plans that are
regulated under Section 1876 of the
Social Security Act, and Employer
Group Plans may also provide a Part D
benefit. If any of the contracting
organizations meet basic requirements,
they may also offer supplemental
benefits through enhanced alternative
coverage for an additional premium.
The information will be collected
under the solicitation of proposals from
PDP, MA–PD, Cost Plan, and Employer
Group Waiver Plans applicants. The
collected information will be used by
CMS to: (1) Insure that applicants meet
CMS requirements, and (2) support the
determination of contract awards.
Refer to the ‘‘High-Level Summary of
Changes in Employer Group Waiver
Plan Part D Applications’’ and ‘‘HighLevel Summary of All Part D
Application Revisions from 2008
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
38601
Solicitation for the 2009 Solicitation’’
documents to review changes from 2008
to 2009; Form Number: CMS–10137
(OMB#: 0938–0936); Frequency:
Reporting: Once; Affected Public:
Business or other for-profit and Not-forprofit institutions; Number of
Respondents: 455; Total Annual
Responses: 455; Total Annual Hours:
11,890.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage (MA) Applications—Part C;
Use: An entity seeking a contract as an
MA organization must be able to
provide Medicare’s basic benefits plus
meet the organizational requirements set
out in regulations at 42 CFR part 422.
An applicant must demonstrate that it
can meet the benefit and other
requirements within the specific
geographic area it is requesting. The
application forms are designed to give
CMS the information they need about
the health plan to determine compliance
with Federal regulations at 42 CFR part
422 in an efficient manner. The cited
regulations outline the MA application
process that begins with submission of
an application in the form and manner
that the Secretary provides. The MA
application forms will be used by CMS
to determine whether an entity is
eligible to enter into a contract to
provide services to Medicare
beneficiaries. Refer to the ‘‘2009
Medicare Advantage Application
Changes’’ document to review a list of
the 2009 changes. Form Number: CMS–
10237 and 10214 (OMB#: 0938–0935);
Frequency: Reporting: Yearly; Affected
Public: Business or other for-profit and
Not-for-profit institutions; Number of
Respondents: 241; Total Annual
Responses: 241; Total Annual Hours:
5,858.
3. Type of Information Collection
Request: New collection; Title of
Information Collection: Revisions to
Payment Policies Under the Physician
Fee Schedule, Other Changes to
Payment Under Part B, and Revisions to
Payment Policies for Ambulance
Services for CY 2008 (42 CFR 424.36—
Signature Requirements); Use: 42 CFR
424.33(a)(3) states that all claims must
be signed by the beneficiary or the
beneficiary’s representative (in
accordance with 42 CFR 424.36(b)). 42
CFR 424.36(a) states that the
beneficiary’s signature is required on a
claim unless the beneficiary has died or
the provisions of § 424.36(b), (c), or (d)
apply. The statutory authority requiring
a beneficiary’s signature on a claim
submitted by a provider is located in
section 1835(a) and in 1814(a) of the
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 72, Number 134 (Friday, July 13, 2007)]
[Notices]
[Pages 38600-38601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-3427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-67776, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 72 FR 35491-35492, dated June 28, 2007) is
amended to reflect the establishment of the Extramural Research Program
Office within the National Center for Chronic Disease Prevention and
Health Promotion, Coordinating Center for Health Promotion, Centers for
Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows: After the functional statement for the Program Services Branch
(CUC13), Office of the Director (CUC1), National Center for Chronic
Disease Prevention and Health Promotion (CUC), insert the following:
Extramural Research Program Office (CUC18). The Extramural Research
Program Office (ERPO) plans, develops,
[[Page 38601]]
coordinates, and evaluates extramural research activities in
cooperation with centers, divisions, and offices within the
Coordinating Center for Health Promotion. In carrying out its mission,
the ERPO: (1) Coordinates, monitors, and directs the extramural
research program which is designed to address center priorities; (2)
provides scientific leadership in the processes supporting extramural
research of the center; (3) works with National Centers to prepare and
promote initiatives to stimulate extramural research in relevant
priority areas; (4) coordinates and conducts in-depth external peer
review and secondary program relevance review of extramural research
applications by use of consultant expert panels; (5) makes
recommendations to the center directors on award selections on the
basis of secondary reviews; (6) staff members serve as the program
officials and work with CDC grants management officers, and the
Procurement and Grants Office to implement and monitor the scientific,
technical, and administrative aspects of awards; (7) facilitates
scientific collaborations between external and internal investigators;
(8) evaluates extramural research progress and impact and disseminates
findings; and (9) assists Office of the Chief Science Officer, CDC, in
developing extramural research policies and oversees the implementation
of those policies within the center.
Dated: June 28, 2007.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 07-3427 Filed 7-12-07; 8:45 am]
BILLING CODE 4160-18-M
